scispace - formally typeset
L

Luís Taborda-Barata

Researcher at University of Beira Interior

Publications -  100
Citations -  1484

Luís Taborda-Barata is an academic researcher from University of Beira Interior. The author has contributed to research in topics: Medicine & Asthma. The author has an hindex of 15, co-authored 70 publications receiving 1159 citations. Previous affiliations of Luís Taborda-Barata include National Institutes of Health & Imperial College London.

Papers
More filters
Journal Article

Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product.

TL;DR: Human eosinophils express mRNA for IL-4, and the translated product is contained within the crystalloid granule from which it is released after stimulation with serum-coated particles, consistent with the hypothesis that eos inophils contribute to the development of the Th2 phenotype by T cells infiltrating atopic allergic reactions.
Journal ArticleDOI

High-affinity IgE Receptor (FceRI)-Bearing Cells in Bronchial Biopsies from Atopic and Nonatopic Asthma

TL;DR: Elevated numbers of high-affinity IgE receptor-bearing cells are a feature of bronchial biopsies of asthmatic subjects, irrespective of their atopic status, according to single and double immunohistochemistry findings.
Journal ArticleDOI

The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment.

TL;DR: The view that MCP-3 is involved in the regulation of the early eosinophil response to specific allergen, whereas RANTES may have more relevance to the later accumulation of T cells and macrophages is supported.
Journal ArticleDOI

Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein.

TL;DR: Human eosinophils have the capacity to synthesize, store and secrete physiologically relevant quantities of RANTES, and may therefore be an important source of this chemokine in allergic inflammation.
Journal ArticleDOI

ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020).

Jean Bousquet, +125 more
- 01 Mar 2021 -